{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:15:22Z","timestamp":1790356522869,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T00:00:00Z","timestamp":1540166400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.tranon.2018.10.008","type":"journal-article","created":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T01:04:10Z","timestamp":1541466250000},"page":"200-208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Targeting PIM Kinases Affects Maintenance of CD133 Tumor Cell Population in Hepatoblastoma"],"prefix":"10.1016","volume":"12","author":[{"given":"Laura L.","family":"Stafman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele P.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan F.","family":"Garner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie M.","family":"Aye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry E.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina J.","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Beierle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.tranon.2018.10.008_bb0005","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/cncr.23169","article-title":"Trends in childhood cancer incidence in the US (1992-2004)","volume":"112","author":"Linabery","year":"2008","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.tranon.2018.10.008_bb0010","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.ejca.2012.10.003","article-title":"Relapses in hepatoblastoma patients: clinical characteristics and outcome--experience of the International Childhood Liver Tumour Strategy Group (SIOPEL)","volume":"49","author":"Semeraro","year":"2013","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1016\/j.tranon.2018.10.008_bb0015","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0959-8049(97)00095-6","article-title":"Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology","volume":"33","author":"von Schweinitz","year":"1997","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.tranon.2018.10.008_bb0020","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/0022-3468(95)90762-9","article-title":"Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma \u2014 a report from the German Cooperative Pediatric Liver Tumor Study HB-89","volume":"30","author":"von Schweinitz","year":"1995","journal-title":"J Pediatr Surg"},{"issue":"8","key":"10.1016\/j.tranon.2018.10.008_bb0025","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1002\/cncr.10858","article-title":"The role of the MDR1 gene in the development of multidrug resistance in human hepatoblastoma: clinical course and in vivo model","volume":"95","author":"Warmann","year":"2002","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.tranon.2018.10.008_bb0030","doi-asserted-by":"crossref","first-page":"24706","DOI":"10.3390\/ijms141224706","article-title":"Multidrug resistance and cancer stem cells in neuroblastoma and hepatoblastoma","volume":"14","author":"Alisi","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.tranon.2018.10.008_bb0035","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.semcancer.2017.02.011","article-title":"Cancer stem cells: The root of tumor recurrence and metastases","volume":"44","author":"Peitzsch","year":"2017","journal-title":"Semin Cancer Biol"},{"issue":"1 Suppl. 1","key":"10.1016\/j.tranon.2018.10.008_bb0040","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1097\/MD.0000000000004766","article-title":"Cancer stem cells: Role in tumor growth, recurrence, metastasis, and treatment resistance","volume":"95","author":"Chang","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"10.1016\/j.tranon.2018.10.008_bb0045","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1182\/blood-2006-05-024687","article-title":"Characterization of stem cell-like cancer cells in immune-competent mice","volume":"108","author":"Kruger","year":"2006","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.tranon.2018.10.008_bb0050","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/labinvest.2008.14","article-title":"The cancer stem cell hypothesis: in search of definitions, markers, and relevance","volume":"88","author":"Shipitsin","year":"2008","journal-title":"Lab Invest"},{"issue":"7","key":"10.1016\/j.tranon.2018.10.008_bb0055","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1053\/j.gastro.2007.04.025","article-title":"Identification and characterization of tumorigenic liver cancer stem\/progenitor cells","volume":"132","author":"Ma","year":"2007","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.tranon.2018.10.008_bb0060","doi-asserted-by":"crossref","first-page":"R10","DOI":"10.1186\/bcr1855","article-title":"Brca1 breast tumors contain distinct CD44+\/CD24- and CD133+ cells with cancer stem cell characteristics","volume":"10","author":"Wright","year":"2008","journal-title":"Breast Cancer Res"},{"issue":"17","key":"10.1016\/j.tranon.2018.10.008_bb0065","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.3748\/wjg.v19.i17.2603","article-title":"CD133: a cancer stem cells marker, is used in colorectal cancers","volume":"19","author":"Ren","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.tranon.2018.10.008_bb0070","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.stem.2007.06.002","article-title":"Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer","volume":"1","author":"Hermann","year":"2007","journal-title":"Cell Stem Cell"},{"issue":"22","key":"10.1016\/j.tranon.2018.10.008_bb0075","doi-asserted-by":"crossref","first-page":"10734","DOI":"10.1073\/pnas.90.22.10734","article-title":"Expression of a Pim-1 transgene accelerates lymphoproliferation and inhibits apoptosis in lpr\/lpr mice","volume":"90","author":"M\u00f6r\u00f6y","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.tranon.2018.10.008_bb0080","first-page":"1941","article-title":"E mu N- and E mu L-myc cooperate with E mu pim-1 to generate lymphoid tumors at high frequency in double-transgenic mice","volume":"6","author":"M\u00f6r\u00f6y","year":"1991","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.tranon.2018.10.008_bb0085","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s10120-011-0097-2","article-title":"Clinical and therapeutic relevance of PIM1 kinase in gastric cancer","volume":"15","author":"Yan","year":"2012","journal-title":"Gastric Cancer"},{"issue":"7","key":"10.1016\/j.tranon.2018.10.008_bb0090","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1593\/neo.13172","article-title":"Functional role and therapeutic potential of the pim-1 kinase in colon carcinoma","volume":"15","author":"Weirauch","year":"2013","journal-title":"Neoplasia"},{"issue":"6","key":"10.1016\/j.tranon.2018.10.008_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130340","article-title":"Pim kinases promote migration and metastatic growth of prostate cancer xenografts","volume":"10","author":"Santio","year":"2015","journal-title":"PLoS One"},{"issue":"15","key":"10.1016\/j.tranon.2018.10.008_bb0100","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1038\/onc.2009.504","article-title":"Accelerated hepatocellular carcinoma development in mice expressing the Pim-3 transgene selectively in the liver","volume":"29","author":"Wu","year":"2010","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.tranon.2018.10.008_bb0105","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/med.21284","article-title":"The PIM family of serine\/threonine kinases in cancer","volume":"34","author":"Narlik-Grassow","year":"2014","journal-title":"Med Res Rev"},{"key":"10.1016\/j.tranon.2018.10.008_bb0110","doi-asserted-by":"crossref","first-page":"22665","DOI":"10.18632\/oncotarget.25205","article-title":"Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma","volume":"9","author":"Stafman","year":"2018","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.tranon.2018.10.008_bb0115","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1593\/tlo.12505","article-title":"FAK inhibition decreases hepatoblastoma survival both in vitro and in vivo","volume":"6","author":"Gillory","year":"2013","journal-title":"Transl Oncol"},{"issue":"2","key":"10.1016\/j.tranon.2018.10.008_bb0120","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jss.2015.03.021","article-title":"Focal adhesion kinase and p53 synergistically decrease neuroblastoma cell survival","volume":"196","author":"Gillory","year":"2015","journal-title":"J Surg Res"},{"issue":"6","key":"10.1016\/j.tranon.2018.10.008_bb0125","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/laban.254","article-title":"Estimation of rat mammary tumor volume using caliper and ultrasonography measurements","volume":"42","author":"Faustino-Rocha","year":"2013","journal-title":"Lab Anim (NY)"},{"issue":"6","key":"10.1016\/j.tranon.2018.10.008_bb0130","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1182\/blood-2013-04-495366","article-title":"AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia","volume":"123","author":"Keeton","year":"2014","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.tranon.2018.10.008_bb0135","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1038\/onc.2014.174","article-title":"Oct4 is a critical regulator of stemness in head and neck squamous carcinoma cells","volume":"34","author":"Koo","year":"2015","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.tranon.2018.10.008_bb0140","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.canlet.2013.07.009","article-title":"Knockdown of Oct4 and Nanog expression inhibits the stemness of pancreatic cancer cells","volume":"340","author":"Lu","year":"2013","journal-title":"Cancer Lett"},{"issue":"4","key":"10.1016\/j.tranon.2018.10.008_bb0145","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.3892\/ijo.2014.2278","article-title":"Nestin regulates proliferation, migration, invasion and stemness of lung adenocarcinoma","volume":"44","author":"Narita","year":"2014","journal-title":"Int J Oncol"},{"issue":"7","key":"10.1016\/j.tranon.2018.10.008_bb0150","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/cas.12691","article-title":"Nestin as a marker of cancer stem cells","volume":"106","author":"Neradil","year":"2015","journal-title":"Cancer Sci"},{"issue":"9","key":"10.1016\/j.tranon.2018.10.008_bb0155","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1002\/stem.2059","article-title":"SRY and OCT4 are required for the acquisition of cancer stem cell-like properties and are potential differentiation therapy targets","volume":"33","author":"Murakami","year":"2015","journal-title":"Stem Cells"},{"issue":"11","key":"10.1016\/j.tranon.2018.10.008_bb0160","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/stem.2447","article-title":"Positive feedback loop of OCT4 and c-JUN expedites cancer stemness in liver cancer","volume":"34","author":"Kuo","year":"2016","journal-title":"Stem Cells"},{"issue":"3","key":"10.1016\/j.tranon.2018.10.008_bb0165","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1385\/MN:34:3:153","article-title":"Strengths and limitations of the neurosphere culture system","volume":"34","author":"Jensen","year":"2006","journal-title":"Mol Neurobiol"},{"issue":"42","key":"10.1016\/j.tranon.2018.10.008_bb0170","doi-asserted-by":"crossref","first-page":"44191","DOI":"10.18632\/oncotarget.6176","article-title":"Cancer stem cell targeted therapy: progress amid controversies","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.tranon.2018.10.008_bb0175","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1002\/ijc.22476","article-title":"CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity","volume":"120","author":"Yin","year":"2007","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.tranon.2018.10.008_bb0180","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.gene.2012.12.106","article-title":"Gene expression signature of human HepG2 cell line","volume":"518","author":"Costantini","year":"2013","journal-title":"Gene"},{"issue":"3","key":"10.1016\/j.tranon.2018.10.008_bb0185","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.trsl.2014.07.009","article-title":"Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data","volume":"165","author":"Bahnassy","year":"2015","journal-title":"Transl Res"},{"issue":"6","key":"10.1016\/j.tranon.2018.10.008_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/toxins8060165","article-title":"CD133, selectively targeting the root of cancer","volume":"8","author":"Schmohl","year":"2016","journal-title":"Toxins (Basel)"},{"issue":"28","key":"10.1016\/j.tranon.2018.10.008_bb0195","doi-asserted-by":"crossref","first-page":"17793","DOI":"10.1021\/acsami.6b04403","article-title":"Targeting colorectal cancer stem- like cells with anti-CD133 antibody- conjugated SN-38 nanoparticles","volume":"8","author":"Ning","year":"2016","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.tranon.2018.10.008_bb0200","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.immunol.25.022106.141609","article-title":"Immunosuppressive strategies that are mediated by tumor cells","volume":"25","author":"Rabinovich","year":"2007","journal-title":"Annu Rev Immunol"},{"issue":"7","key":"10.1016\/j.tranon.2018.10.008_bb0205","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1440169","article-title":"CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial","volume":"7","author":"Wang","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.tranon.2018.10.008_bb0210","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.pharmthera.2016.02.008","article-title":"Cancer stem cells and chemoresistance: The smartest survives the raid","volume":"160","author":"Zhao","year":"2016","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.tranon.2018.10.008_bb0215","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2001-1326-2-3","article-title":"Mechanisms of chemoresistance in cancer stem cells","volume":"2","author":"Abdullah","year":"2013","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.tranon.2018.10.008_bb0220","doi-asserted-by":"crossref","first-page":"3714190","DOI":"10.1155\/2017\/3714190","article-title":"Cancer stem cells and their microenvironment: biology and therapeutic implications","volume":"2017","author":"Lau","year":"2017","journal-title":"Stem Cells Int"},{"issue":"5","key":"10.1016\/j.tranon.2018.10.008_bb0225","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1158\/1535-7163.MCT-13-0575-T","article-title":"PIM kinases are essential for chronic lymphocytic leukemia cell survival (PIM2\/3) and CXCR4-mediated microenvironmental interactions (PIM1)","volume":"13","author":"Decker","year":"2014","journal-title":"Mol Cancer Ther"},{"issue":"32","key":"10.1016\/j.tranon.2018.10.008_bb0230","doi-asserted-by":"crossref","first-page":"4428","DOI":"10.1038\/s41388-018-0263-7","article-title":"Fibroblast-derived CXCL12 promotes breast cancer metastasis by facilitating tumor cell intravasation","volume":"37","author":"Ahirwar","year":"2018","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.tranon.2018.10.008_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079798","article-title":"Differential effects of drugs targeting cancer stem cell (CSC) and non-CSC populations on lung primary tumors and metastasis","volume":"8","author":"Larzabal","year":"2013","journal-title":"PLoS One"},{"issue":"Suppl. 2","key":"10.1016\/j.tranon.2018.10.008_bb0240","doi-asserted-by":"crossref","first-page":"77S","DOI":"10.2967\/jnumed.116.186874","article-title":"CXCR4 Ligands: The Next Big Hit?","volume":"58","author":"Walenkamp","year":"2017","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1016\/j.tranon.2018.10.008_bb0245","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1590\/1414-431X20143415","article-title":"Liver cancer stem cells are selectively enriched by low-dose cisplatin","volume":"47","author":"Zhang","year":"2014","journal-title":"Braz J Med Biol Res"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523318304327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523318304327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T14:35:36Z","timestamp":1761834936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523318304327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S1936523318304327"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2018.10.008","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting PIM Kinases Affects Maintenance of CD133 Tumor Cell Population in Hepatoblastoma","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2018.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc. on behalf of Neoplasia Press, Inc.","name":"copyright","label":"Copyright"}]}}